Table 1: Immunological parameters in a liver recipient treated with mucosal bacterial immunotherapy.
Parameter |
06.12 |
03.13 |
11.13 |
10.14 |
04.18 |
02.19 |
IgG mg/dL |
447 |
592 |
675 |
799 |
769 |
652 |
IgG2 mg/dL |
0.386 |
- |
- |
- |
0.77 |
0.456 |
IgG4 mg/dl |
0.01 |
- |
- |
- |
0.014 |
0.01 |
Anti-PPS mg/dL |
0.8 |
0.6 |
1.7 |
0.5 |
0.3 |
1 |
C3 mg/dL |
78 |
80 |
82 |
87 |
80 |
93 |
CD4 cells/uL |
480 |
439 |
381 |
441 |
546 |
586 |
NK cells/uL |
8 |
7 |
7 |
26 |
44 |
56 |
PPS vaccine, type |
- |
PS-23 |
- |
CONJ-13 |
- |
PS-23 |
MBI, months |
3 |
3 |
3 |
3 |
3 |
3 |
Anti-PPS: anti pneumococcal polysaccharide IgG titers; CONJ-13: 13 serotypes conjugated pneumococcal vaccine; MBI: mucosal bacterial immunotherapy; PPS: pneumococcal polysaccharide; PPS vaccine: pneumococcal vaccine; PS-23: 23 serotypes pneumococcal polysaccharide vaccine.